Take Control of Your Weight. Backed by Medical Science.
GLP-1 medications prescribed by licensed doctors. Delivered discreetly to your door.
Our Featured Treatments
Semaglutide
- FDA-approved for weight management
- Clinically proven results
- Board-certified physician oversight
Tirzepatide
- Dual-action GLP-1 therapy
- Enhanced weight loss outcomes
- Convenient home delivery
Why Choose Oral Tirzepatide for Weight Loss?
A convenient, doctor-guided approach to GLP-1 weight loss without injections.
No Injections Required
Appetite Control Support
Doctor-Guided Treatment
Simple Online Process
How Oral Tirzepatide Compares to Leading GLP-1 Treatments
Oral tirzepatide offers a more convenient alternative to traditional GLP-1 medications like Wegovy and Zepbound, while still supporting effective weight loss under medical supervision.
| Feature | Oral Tirzepatide | Wegovy (Semaglutide) | Zepbound (Tirzepatide) |
|---|---|---|---|
| Administration | Oral medication (no injections) | Weekly injection | Weekly injection |
| Convenience | High (daily oral option) | Moderate | Moderate |
| Medical Supervision | Required | Required | Required |
| Effectiveness | Emerging clinical data | Clinically proven | Clinically proven |
| Best For | Patients who prefer no injections | Patients comfortable with injections | Patients seeking maximum results |
Is oral tirzepatide better than other GLP-1 medications?
Oral tirzepatide may be a better option for patients who want a more convenient, injection-free treatment. Injectable GLP-1 medications currently have stronger clinical data, but oral options are rapidly gaining popularity.
Why Patients Are Choosing Oral Tirzepatide
- No needles or injections required
- Convenient daily oral dosing
- Board-certified physician oversight
- Delivered directly to your door
- Ongoing clinical monitoring and support
GLP News
Subscribe to recieve updates!
Real Patients. Real Results.
Common Questions About GLP-1 Weight Loss
-
Most patients lose 10–20% of their body weight over 6–12 months under medical supervision. Clinical trials show tirzepatide averaging up to 22.5% body weight reduction, while semaglutide averages 15%.
-
Semaglutide is a GLP-1 receptor agonist FDA-approved for chronic weight management. It works by suppressing appetite and slowing gastric emptying, leading to significant weight loss.
-
Tirzepatide is a dual GIP/GLP-1 receptor agonist FDA-approved for weight loss. Clinical trials show it produces greater average weight loss than semaglutide alone.
-
Yes — when prescribed by a licensed physician through a HIPAA-compliant telehealth platform. DietsMD requires a full medical evaluation before any prescription is issued.
-
Programs at DietsMD include physician consultations, medication, and ongoing support. Contact us for current pricing — no insurance required.